CPAP segment, by Product Type to Account Largest Share in Positive Airway Pressure Devices Market during 2023-2031

According to our new research study on "Positive Airway Pressure Devices Market Forecast to 2031 - Global Analysis - by Product Type, Application, and End User, and Geography," the market was valued at US$ 6,291.58 million in 2023 and is projected to reach US$ 10,544.70 million by 2031; it is expected to register a CAGR of 6.7% during 2023-2031. The increasing demand for positive airway pressure devices and the growing shift toward home healthcare are contributing to the growing positive airway pressure devices market size. However, product recall hampers the market growth. Further, technological advancements in positive airway pressure devices are expected to bring in new market trends in the coming years.

Historically, sleep apnea was managed using CPAP machines, lifestyle modifications, and surgical procedures. However, new developments in sleep apnea treatment technology are transforming the diagnosis, tracking, and treatment. The management of sleep apnea has become more convenient, practical, and comfortable due to the development of cutting-edge diagnostic tools, inventive treatment devices, and remote monitoring capabilities. The technological developments are likely to improve the lives of people with sleep apnea. For example, the SleepStyle CPAP is renowned for its integrated humidifier and user-friendly interface. This has a smartphone app for compliance and monitoring, as well as Bluetooth connectivity. The small and lightweight Somnetics Transcend 3 Mini CPAP features cutting-edge noise-cancelling technology. It has Bluetooth connectivity, intelligent pressure adjustments, and is travel-friendly. In order to anticipate apnea episodes during sleep, NovaResp Technologies Inc. is creating an artificial intelligence (AI)-enabled CPAP algorithm to work with any CPAP, including the device that the company is currently developing.

These innovations are expanding the market and giving businesses a competitive edge when managing respiratory conditions such as sleep apnea and have high adoption rates.

The positive airway pressure devices market analysis has been carried out by considering the following segments: product type, application, end user, and geography.

Based on product type, the market is segmented into CPAP devices, APAP devices, and BiPAP devices. The CPAP segment held the largest positive airway pressure devices market share in 2023. Continuous positive airway pressure (CPAP) therapy is a commonly used treatment for obstructive sleep apnea. A CPAP machine has a hose connected to a mask or nosepiece to deliver consistent, steady air pressure, which helps in breathing while sleeping. The prevalence of sleep apnea is increasing globally due to obesity and a sedentary lifestyle, leading to a growing demand for CPAP devices. CPAP device manufacturers offer a range of products, including standalone devices, combination devices [CPAP and bilevel positive airway pressure (BiPAP)], and portable devices.

CPAP devices significantly improve sleep quality and may reduce the risk of stroke. With the help of CPAP therapy over an extended period, the chances of various heart problems, such as congestive heart failure, coronary artery disease, and irregular heartbeat, can be remarkably reduced. Some other benefits of CPAP devices include alertness during the daytime, concentration, emotional stability, and low medical expenses. Koninklijke Philips N.V.; Devilbiss Healthcare LLC; 3B Medical, Inc.; and ResMed, Inc are among the popular CPAP device manufacturers.

By application, the market is categorized into chronic obstructive pulmonary disease, obstructive sleep apnea, and respiratory distress. The obstructive sleep apnea segment held the largest share of the market in 2023. PAP devices are commonly used to treat obstructive sleep apnea, a condition marked by frequent episodes of shallow or paused breathing during sleep. These devices operate by delivering a continuous stream of air pressure into the patient's airway to keep it open and prevent breathing from getting paused.

The growing prevalence of obstructive sleep apnea worldwide is fueling the global PAP device market. According to the data released by the American Medical Association in April 2022, an estimated 30 million people in the US had sleep apnea, of which only 6 million were diagnosed. PAP devices are proven to be an effective treatment for obstructive sleep apnea demonstrating significant improvements in symptoms and quality of life.

Further, market players are adopting organic growth strategies for market development. For instance, in August 2021, ResMed introduced the AirSense 11, its latest CPAP machine, featuring a range of new functions to address obstructive sleep apnea.

Based on end user, the positive airway pressure devices market is categorized into hospitals, ambulatory surgical centers, and home care rehabilitation centers. The hospitals and specialty clinics segment dominated the market in 2023. Hospitals are primary contact points for patients for the diagnosis and treatment of various conditions. Infrastructure available in hospitals helps professionals provide high-quality care for patients. The hospitals segment is expected to hold a considerable share due to high patient visits. Multispecialty hospitals offer diagnostic and therapeutic services for various sleep disorders. Moreover, hospitals help patients through reimbursement provisions and assistance.

The demand for PAP devices in hospitals is rising due to increasing awareness of sleep apnea and the effectiveness of PAP therapy in treating respiratory conditions. Hospitals such as Johns Hopkins Hospital (Baltimore, Maryland); Massachusetts General Hospital (Boston, Massachusetts); University of California, Los Angeles (UCLA) Medical Center (Los Angeles, California); and Duke University Health System (Durham, North Carolina) use PAP devices for treating sleep apnea and other respiratory conditions.

ICU Medical Inc, React Health (Formely 3B Medical, Inc), Fisher & Paykel Healthcare Corp Ltd, BPL Medical Technologies Pvt Ltd, Koninklijke Philips NV, ResMed Inc, Vyaire Medical Inc, Wellell Inc, Armstrong Medical Ltd, Löwenstein Medical UK Ltd., BMC Medical Co Ltd, Dragerwerk AG & Co KGaA, and Narang Medical Limited are among the leading companies operating in the global positive airway pressure devices market.

Companies operating in the positive airway pressure devices market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the positive airway pressure devices market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall positive airway pressure devices market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.


Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com